To investigate whether the induction of IFN-I responses in RTT tumours could synergize with COX2 inhibition, we used 5-azacitidine (5-AZA), a clinically used DNA methyltransferase inhibitor that induces IFN-I responses54. Here, PTGER2 is linked to neoplasm.